Literature DB >> 23901427

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.

.   

Abstract

BACKGROUND: The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent rectal cancer (RRC) is challenging. There is global variation in standards and no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, beyond conventional total mesorectal excision planes. The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority.
METHODS: Delphi methodology was used to achieve consensus. The Group consisted of invited experts from surgery, radiology, oncology and pathology. The process included two international dedicated discussion conferences, formal feedback, three rounds of editing and two rounds of anonymized web-based voting. Consensus was achieved with more than 80 per cent agreement; less than 80 per cent agreement indicated low consensus. During conferences held in September 2011 and March 2012, open discussion took place on areas in which there is a low level of consensus.
RESULTS: The final consensus document included 51 voted statements, making recommendations on ten key areas of PRC-bTME and RRC. Consensus agreement was achieved on the recommendations of 49 statements, with 34 achieving consensus in over 95 per cent. The lowest level of consensus obtained was 76 per cent. There was clear identification of the need for referral to a specialist multidisciplinary team for diagnosis, assessment and further management.
CONCLUSION: The consensus process has provided guidance for the management of patients with PRC-bTME or RRC, taking into account global variations in surgical techniques and technology. It has further identified areas of research priority.

Entities:  

Mesh:

Year:  2013        PMID: 23901427     DOI: 10.1002/bjs.9192_1

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  18 in total

1.  Striking similarities in genetic aberrations between a rectal tumor and its lung recurrence.

Authors:  Osama E Rahma; Mauricio Burotto; Luisa Matos Do Canto; Alexandre A Germanos; Bassem R Haddad; John L Marshall
Journal:  World J Gastrointest Oncol       Date:  2013-11-15

Review 2.  Locally Advanced Disease and Pelvic Exenterations.

Authors:  Christos Kontovounisios; Paris Tekkis
Journal:  Clin Colon Rectal Surg       Date:  2017-12-01

3.  Feasibility of robotic assisted bladder sparing pelvic exenteration for locally advanced rectal cancer: A single institution case series.

Authors:  Nathaniel H Heah; Kar Yong Wong
Journal:  World J Gastrointest Surg       Date:  2020-04-27

4.  Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.

Authors:  F Selvaggi; C Fucini; G Pellino; G Sciaudone; I Maretto; I Mondi; N Bartolini; F Caminati; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2014-11-11       Impact factor: 3.781

5.  Evaluating potential delays and outcomes of patients undergoing surgical resection for locally advanced and recurrent colorectal cancer during a pandemic.

Authors:  M A Javed; A Kohler; J Tiernan; A Quyn; P Sagar
Journal:  Ann R Coll Surg Engl       Date:  2022-02-08       Impact factor: 1.951

Review 6.  Colorectal cancer.

Authors:  Ernst J Kuipers; William M Grady; David Lieberman; Thomas Seufferlein; Joseph J Sung; Petra G Boelens; Cornelis J H van de Velde; Toshiaki Watanabe
Journal:  Nat Rev Dis Primers       Date:  2015-11-05       Impact factor: 52.329

7.  Intraoperative bleeding and haemostasis during pelvic surgery for locally advanced or recurrent rectal cancer: a prospective evaluation.

Authors:  V A Bonello; A Bhangu; J E F Fitzgerald; S Rasheed; P Tekkis
Journal:  Tech Coloproctol       Date:  2014-06-03       Impact factor: 3.781

Review 8.  Pelvic exenteration for locally advanced and recurrent rectal cancer-how much more?

Authors:  Yee Chen Lau; Kilian G M Brown; Peter Lee
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 9.  Clinical review: surgical management of locally advanced and recurrent colorectal cancer.

Authors:  D Courtney; F McDermott; A Heeney; D C Winter
Journal:  Langenbecks Arch Surg       Date:  2013-11-19       Impact factor: 3.445

10.  Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study.

Authors:  Ewa Kosakowska; Lucyna Pietrzak; Wojciech Michalski; Lucyna Kepka; Wojciech Polkowski; Malgorzata Jankiewicz; Bogumila Cisel; Jacek Krynski; Jacek Zwolinski; Lucjan Wyrwicz; Andrzej Rutkowski; Roman Stylinski; Grzegorz Nawrocki; Rafal Sopylo; Marek Szczepkowski; Wieslaw Tarnowski; Krzysztof Bujko
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.